BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8832669)

  • 21. Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH.
    Gilbert B; Perfetti L; Fauchoux O; Redondo J; Baudat PA; Andres R; Neumann M; Steen S; Gabel D; Mercanti D; Ciotti MT; Perfetti P; Margaritondo G; De Stasio G
    Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics; 2000 Jul; 62(1 Pt B):1110-8. PubMed ID: 11088567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Rezvani M
    Radiother Oncol; 1994 Aug; 32(2):144-53. PubMed ID: 7972908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding and distribution of Na2B12H11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy.
    Otersen B; Haritz D; Grochulla F; Bergmann M; Sierralta W; Gabel D
    J Neurooncol; 1997 May; 33(1-2):131-9. PubMed ID: 9151230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
    Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA.
    Garabalino MA; Heber EM; Monti Hughes A; Pozzi EC; Molinari AJ; Nigg DW; Bauer W; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2014 Jun; 88():64-8. PubMed ID: 24360859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell type selective accumulation of mercaptoundecahydro- closo-dodecaborate (BSH) in glioblastoma multiforme.
    Neumann M; Bergmann M; Gabel D
    Acta Neurochir (Wien); 2003 Nov; 145(11):971-5. PubMed ID: 14628202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the subcellular distribution of mercaptoundecahydro-closo-dodecaborate (BSH) in human glioblastoma multiforme by electron microscopy.
    Neumann M; Kunz U; Lehmann H; Gabel D
    J Neurooncol; 2002 Apr; 57(2):97-104. PubMed ID: 12125978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model.
    Ceberg CP; Brun A; Kahl SB; Koo MS; Persson BR; Salford LG
    J Neurosurg; 1995 Jul; 83(1):86-92. PubMed ID: 7782856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
    Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
    Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Boron neutron capture irradiation of the rat spinal cord: effects of variable doses of borocaptate sodium.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Fisher C
    Radiother Oncol; 1996 Jun; 39(3):253-9. PubMed ID: 8783402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcellular boron-10 localization in glioblastoma for boron neutron capture therapy with Na2B12H11SH.
    Haselsberger K; Radner H; Gössler W; Schlagenhaufen C; Pendl G
    J Neurosurg; 1994 Nov; 81(5):741-4. PubMed ID: 7931621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boron neutron capture therapy: long-term effects on the skin and spinal cord of the rat.
    Morris GM; Constantine G; Ross G; Yeung TK; Hopewell JW
    Radiat Res; 1993 Sep; 135(3):380-6. PubMed ID: 8378531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
    Mehta SC; Boudinot FD; Lu DR
    Drug Metab Dispos; 1995 Dec; 23(12):1368-71. PubMed ID: 8689945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy.
    Elowitz EH; Bergland RM; Coderre JA; Joel DD; Chadha M; Chanana AD
    Neurosurgery; 1998 Mar; 42(3):463-8; discussion 468-9. PubMed ID: 9526978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial.
    Hideghéty K; Sauerwein W; Wittig A; Götz C; Paquis P; Grochulla F; Haselsberger K; Wolbers J; Moss R; Huiskamp R; Fankhauser H; de Vries M; Gabel D
    J Neurooncol; 2003; 62(1-2):145-56. PubMed ID: 12749710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
    Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
    Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.